<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00628823</url>
  </required_header>
  <id_info>
    <org_study_id>SA-115376</org_study_id>
    <nct_id>NCT00628823</nct_id>
  </id_info>
  <brief_title>Treatment of Mild Enteropathy Celiac Disease</brief_title>
  <acronym>TMCD</acronym>
  <official_title>Treatment of Mild Enteropathy Celiac Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Academy of Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Tampere</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to evaluate the natural history of gluten sensitivity in
      endomysial antibody positive adults with celiac disease suspicion, who were found to have a
      only mild enteropathy (Marsh I-II) in the small-bowel mucosa. The investigators hypothesize
      that these subject are indeed gluten-sensitive, as measured by clinical, serological and
      histological indicators. If this would be the case, the current diagnostic criteria for
      celiac disease might need re-evaluation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current diagnostic criteria of celiac disease require small-bowel mucosal villous atrophy
      with crypt hyperplasia (Marsh III). However, the mucosal damage develops gradually and the
      patients may have clinical symptoms and endomysial antibodies before the development of
      villous atrophy.

      The main purpose of this study is to evaluate the natural history of gluten sensitivity in
      endomysial antibody positive adults with celiac disease suspicion, who were found to have a
      only mild enteropathy (Marsh I-II) in the small-bowel mucosa. We hypothesize that these
      subject are indeed gluten-sensitive, as measured by clinical, serological and histological
      indicators. If this would be the case, the current diagnostic criteria for celiac disease
      might need re-evaluation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2003</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Small-Bowel mucosal morphology</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Endomysial antibodies, tissue transglutaminase antibodies, Small-Bowel mucosal inflammation, clinical symptoms, laboratory parameters, bone mineral density.</measure>
    <time_frame>One year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">73</enrollment>
  <condition>Celiac Disease</condition>
  <arm_group>
    <arm_group_label>A1</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Gluten-containing diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Gluten-free diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Gluten-free diet</intervention_name>
    <description>Gluten containing foods removed from diet</description>
    <arm_group_label>A2</arm_group_label>
    <other_name>No other names</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Celiac disease suspicion

          -  Positive endomysial antibodies

          -  At least Marsh I -type small-bowel mucosal lesion

        Exclusion Criteria:

          -  Earlier celiac disease diagnosis

          -  Consuming oral corticosteroids or immune suppressants
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katri Kaukinen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Tampere</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Tampere</name>
      <address>
        <city>Tampere</city>
        <zip>33014</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2008</study_first_submitted>
  <study_first_submitted_qc>February 24, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2008</study_first_posted>
  <last_update_submitted>May 14, 2016</last_update_submitted>
  <last_update_submitted_qc>May 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tampere University Hospital</investigator_affiliation>
    <investigator_full_name>Kalle Kurppa</investigator_full_name>
    <investigator_title>MD., PhD</investigator_title>
  </responsible_party>
  <keyword>Celiac Disease</keyword>
  <keyword>Endomysial antibodies</keyword>
  <keyword>Mild enteropathy</keyword>
  <keyword>Treatment</keyword>
  <keyword>Gluten-free diet</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Celiac Disease</mesh_term>
    <mesh_term>Intestinal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

